- Home
- TACT vs DTIL Comparison
TACT vs DTIL Comparison
Compare TACT & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TACT
- DTIL
- Stock Information
- Founded
- TACT 1996
- DTIL 2006
- Country
- TACT United States
- DTIL United States
- Employees
- TACT N/A
- DTIL N/A
- Industry
- TACT Computer peripheral equipment
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- TACT Technology
- DTIL Health Care
- Exchange
- TACT Nasdaq
- DTIL Nasdaq
- Market Cap
- TACT 44.1M
- DTIL 43.3M
- IPO Year
- TACT 1996
- DTIL 2019
- Fundamental
- Price
- TACT $3.93
- DTIL $5.18
- Analyst Decision
- TACT Strong Buy
- DTIL Strong Buy
- Analyst Count
- TACT 1
- DTIL 3
- Target Price
- TACT $7.50
- DTIL $37.67
- AVG Volume (30 Days)
- TACT 13.6K
- DTIL 126.7K
- Earning Date
- TACT 03-18-2025
- DTIL 03-26-2025
- Dividend Yield
- TACT N/A
- DTIL N/A
- EPS Growth
- TACT N/A
- DTIL N/A
- EPS
- TACT N/A
- DTIL 1.45
- Revenue
- TACT $46,418,000.00
- DTIL $75,096,000.00
- Revenue This Year
- TACT N/A
- DTIL $51.35
- Revenue Next Year
- TACT $16.86
- DTIL N/A
- P/E Ratio
- TACT N/A
- DTIL $2.68
- Revenue Growth
- TACT N/A
- DTIL 43.62
- 52 Week Low
- TACT $3.32
- DTIL $3.61
- 52 Week High
- TACT $7.13
- DTIL $15.97
- Technical
- Relative Strength Index (RSI)
- TACT 36.84
- DTIL 48.52
- Support Level
- TACT $3.75
- DTIL $4.69
- Resistance Level
- TACT $4.13
- DTIL $5.33
- Average True Range (ATR)
- TACT 0.21
- DTIL 0.39
- MACD
- TACT -0.03
- DTIL -0.04
- Stochastic Oscillator
- TACT 25.71
- DTIL 34.75
About TACT TransAct Technologies Incorporated
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.